Literature DB >> 20367845

The limitations of randomized controlled trials in predicting effectiveness.

Nancy Cartwright1, Eileen Munro.   

Abstract

What kinds of evidence reliably support predictions of effectiveness for health and social care interventions? There is increasing reliance, not only for health care policy and practice but also for more general social and economic policy deliberation, on evidence that comes from studies whose basic logic is that of JS Mill's method of difference. These include randomized controlled trials, case-control studies, cohort studies, and some uses of causal Bayes nets and counterfactual-licensing models like ones commonly developed in econometrics. The topic of this paper is the 'external validity' of causal conclusions from these kinds of studies. We shall argue two claims. Claim, negative: external validity is the wrong idea; claim, positive: 'capacities' are almost always the right idea, if there is a right idea to be had. If we are right about these claims, it makes big problems for policy decisions. Many advice guides for grading policy predictions give top grades to a proposed policy if it has two good Mill's-method-of difference studies that support it. But if capacities are to serve as the conduit for support from a method-of-difference study to an effectiveness prediction, much more evidence, and much different in kind, is required. We will illustrate the complexities involved with the case of multisystemic therapy, an internationally adopted intervention to try to diminish antisocial behaviour in young people.

Entities:  

Mesh:

Year:  2010        PMID: 20367845     DOI: 10.1111/j.1365-2753.2010.01382.x

Source DB:  PubMed          Journal:  J Eval Clin Pract        ISSN: 1356-1294            Impact factor:   2.431


  17 in total

Review 1.  Explanatory models are needed to integrate RCT and observational data with the patient's unique biology.

Authors:  Vijay Sharma; Rubin Minhas
Journal:  J R Soc Med       Date:  2012-01       Impact factor: 5.344

2.  Choosing a patient-reported outcome measure.

Authors:  Leah M McClimans; John Browne
Journal:  Theor Med Bioeth       Date:  2011-02

3.  Understanding and Avoiding Immortal-Time Bias in Gastrointestinal Observational Research.

Authors:  Laura E Targownik; Samy Suissa
Journal:  Am J Gastroenterol       Date:  2015-09-01       Impact factor: 10.864

4.  Developing a reporting guideline for social and psychological intervention trials.

Authors:  Paul Montgomery; Evan Mayo-Wilson; Sally Hopewell; Geraldine Macdonald; David Moher; Sean Grant
Journal:  Am J Public Health       Date:  2013-08-15       Impact factor: 9.308

5.  The effectiveness of psychodynamic psychotherapies: An update.

Authors:  Peter Fonagy
Journal:  World Psychiatry       Date:  2015-06       Impact factor: 49.548

6.  What's in a gold standard? In defence of randomised controlled trials.

Authors:  Marius Backmann
Journal:  Med Health Care Philos       Date:  2017-12

7.  Integrating the Integrated: Merging Integrated Dual Diagnosis Treatment (IDDT) with Housing First.

Authors:  Janice Pringle; Kim Grasso; Lisa Lederer
Journal:  Community Ment Health J       Date:  2017-02-09

Review 8.  A systematic review of the effectiveness of smoking cessation interventions among patients with tuberculosis.

Authors:  E Whitehouse; J Lai; J E Golub; J E Farley
Journal:  Public Health Action       Date:  2018-06-21

9.  Single-Case Design, Analysis, and Quality Assessment for Intervention Research.

Authors:  Michele A Lobo; Mariola Moeyaert; Andrea Baraldi Cunha; Iryna Babik
Journal:  J Neurol Phys Ther       Date:  2017-07       Impact factor: 3.649

10.  Patient-specific devices and population-level evidence: evaluating therapeutic interventions with inherent variation.

Authors:  Mary Jean Walker
Journal:  Med Health Care Philos       Date:  2018-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.